Avanos Medical (AVNS) Expected to Announce Quarterly Earnings on Tuesday

Avanos Medical (NYSE:AVNS) is projected to issue its quarterly earnings data before the market opens on Tuesday, February 18th. Analysts expect the company to announce earnings of $0.40 per share and revenue of $177.23 million for the quarter.

Avanos Medical Stock Down 0.5 %

AVNS stock opened at $16.55 on Friday. Avanos Medical has a twelve month low of $14.98 and a twelve month high of $25.36. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $760.59 million, a P/E ratio of 48.68 and a beta of 0.98. The firm has a 50 day simple moving average of $16.49 and a 200-day simple moving average of $20.12.

Analysts Set New Price Targets

Separately, StockNews.com downgraded shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.